Preventing NSAID-Induced Gastrointestinal Toxicity

This publication has 26 references indexed in Scilit:

• Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis.
  Annals of the Rheumatic Diseases, 1993
• THE GASTRODUODENAL SAFETY AND EFFICACY OF THE FIXED COMBINATION OF DICLOFENAC AND MISOPROSTOL IN THE TREATMENT OF OSTEOARTHRITIS
  Rheumatology, 1992
• A Doubleblind Comparison of the Gastroduodenal Safety and Efficacy of Diclofenac and a Fixed Dose Combination of Diclofenac and Misoprostol in the Treatment of Rheumatoid Arthritis
  Scandinavian Journal of Rheumatology, 1992
• Making Sense of NSAID Gastropathy and Considering the Therapeutic Options
  Scandinavian Journal of Rheumatology, 1992
• Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs
  Annals of Internal Medicine, 1991
• Economic evaluation of prophylactic treatment with Misoprostol in osteoarthritic patients treated with NSAIDs. The case of Belgium.
  1990
• UPPER GASTROINTESTINAL-BLEEDING ASSOCIATED WITH USE OF ANTI-INFLAMMATORY DRUGS
  1989
• PREVENTION OF NSAID-INDUCED GASTRIC ULCER WITH MISOPROSTOL: MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
  The Lancet, 1988
• Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.
  BMJ, 1988
• Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.
  Gut, 1987